...
机译:设计,合成和表征一系列细胞色素P_(450)3A激活的前药(HepDirect前药),可用于将基于磷酸盐的药物靶向肝
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Medicinal Chemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Biochemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Biochemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
Departments of Biochemistry, Metabasis Therapeutics, Inc., 9390 Towne Centre Drive, Building 300, San Diego, California 92121;
机译:使用HepDirect〜1前药进行肝靶向药物递送
机译:限制阿片样肽环状前药细胞渗透的因素,第4部分:两种新的环状前药的生物药物和理化特性的表征,这两种新的环状前药被设计成对肠粘膜中细胞色素P-450酶的氧化代谢稳定,
机译:细胞色素P450激活的前药:靶向药物递送。
机译:纤维素纳米颗粒基酯前药,用于潜在的结肠特异性药物递送。合成物理化学表征和药物释放研究(PPT)
机译:氧化还原敏感聚合物和前药的合成与表征靶向药物递送
机译:设计合成和研究新型一氧化氮(NO)释放前药作为治疗缺血性疾病的候选药物:释放NO的前药生物转化和血红蛋白-NO生化的见解
机译:对新的氯甲基二氢吲哚被细胞色素P450亚型代谢活化的研究。靶向癌症中的药物代谢酶:分析所选细胞色素P450氧化新型癌症前药的作用和功能